Research Guides
SS-31 (Elamipretide): Structure, Mitochondrial Mechanism, and Research Applications
SS-31 is a mitochondria-targeted tetrapeptide studied extensively in preclinical models of oxidative stress. Here's what the published research literature shows about how it works.
What Is SS-31?
SS-31, also known as elamipretide, is a synthetic tetrapeptide (H-D-Arg-Dmt-Lys-Phe-NH2) developed by researchers Peter W. Schiller and Hazel H. Szeto. It belongs to a class of compounds known as Szeto-Schiller (SS) peptides, characterized by an alternating sequence of cationic and aromatic amino acid residues. This structural motif is what allows the molecule to cross cell membranes efficiently and concentrate specifically at the mitochondrial inner membrane.
Mechanism: Targeting the Mitochondrial Inner Membrane
Research published in Redox Biology and related journals shows that SS-31 accumulates 1,000 to 5,000-fold at the mitochondrial inner membrane relative to surrounding tissue, entering cells in an energy-independent, non-saturable manner. Structural studies indicate the peptide interacts with cardiolipin — a phospholipid unique to the inner mitochondrial membrane that plays a central role in maintaining respiratory chain function. By binding lipid bilayers and modulating surface electrostatics, SS-31 is proposed to stabilize cardiolipin and reduce its peroxidation, a process associated with impaired mitochondrial function.
Observed Effects in Cell and Animal Models
Across numerous independent research groups using cell-culture and animal-disease models, SS-31 has been studied for its effects on mitochondrial bioenergetics, including:
- Electron transport efficiency — studies with isolated mitochondria report improved electron transfer and increased ATP production alongside reduced electron leak.
- Reactive oxygen species (ROS) reduction — cell-culture research shows decreased intracellular ROS and reduced lipid peroxidation under induced oxidative stress conditions.
- Membrane potential maintenance — research models report SS-31's role in preserving mitochondrial membrane potential (ΔΨm) under stress conditions such as ischemia and hypoxia.
Research Model Applications
Published preclinical literature has examined SS-31 across a wide range of disease models where mitochondrial dysfunction plays a central role, including cardiomyopathy, skeletal muscle injury, ischemia-reperfusion injury, kidney injury models, and neurodegenerative disease models. It's worth noting that elamipretide has also progressed into human clinical trials conducted by pharmaceutical developers for specific mitochondrial disorders — a distinction that separates it from research-only compounds with no clinical trial history. For laboratory research purposes, SS-31 is studied strictly within controlled preclinical models, not administered outside of regulated clinical trial settings.
Why Compound Purity Matters for Reproducibility
Given SS-31's precise mechanism of binding cardiolipin and modulating membrane electrostatics, even small variations in peptide purity or sequence integrity can affect experimental outcomes. Verifying compound identity and purity through third-party testing is essential for any lab aiming to reproduce or build on existing SS-31 research findings.
Sourcing Research-Grade SS-31
Apex Research Chemicals supplies SS-31 with a Certificate of Analysis (COA) confirming purity and identity through independent third-party testing, available on the product page for research verification.
